Douglas Charney

723 total citations
18 papers, 540 citations indexed

About

Douglas Charney is a scholar working on Nephrology, Transplantation and Pathology and Forensic Medicine. According to data from OpenAlex, Douglas Charney has authored 18 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Transplantation and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Douglas Charney's work include Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Polyomavirus and related diseases (3 papers). Douglas Charney is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Polyomavirus and related diseases (3 papers). Douglas Charney collaborates with scholars based in United States. Douglas Charney's co-authors include Louis Flancbaum, Jason T. Machan, Pierre M. Gholam, Donald P. Kotler, Tibor Nádasdy, Lorraine C. Racusen, Steven M. Keller, Manju L. Prasad, Carl Teplitz and V. S. Ghali and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and The American Journal of Surgical Pathology.

In The Last Decade

Douglas Charney

17 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Charney United States 12 243 119 106 101 98 18 540
Giuseppe Aimo Italy 16 204 0.8× 31 0.3× 190 1.8× 110 1.1× 63 0.6× 44 749
J.W. van der Pijl Netherlands 14 61 0.3× 145 1.2× 322 3.0× 254 2.5× 120 1.2× 25 701
M. L. Maestro Spain 13 92 0.4× 32 0.3× 44 0.4× 24 0.2× 53 0.5× 27 459
G. Mazzola Italy 14 59 0.2× 38 0.3× 51 0.5× 29 0.3× 158 1.6× 40 607
Akinari Sekine Japan 12 88 0.4× 47 0.4× 110 1.0× 15 0.1× 272 2.8× 113 667
H. J. Schlitt Germany 12 69 0.3× 48 0.4× 134 1.3× 63 0.6× 36 0.4× 37 374
Andrea Buonamano Italy 8 62 0.3× 121 1.0× 97 0.9× 98 1.0× 9 0.1× 8 510
Philip Ruiz United States 17 62 0.3× 10 0.1× 283 2.7× 148 1.5× 88 0.9× 30 795
GP Herzig United States 12 47 0.2× 23 0.2× 36 0.3× 64 0.6× 38 0.4× 14 870
J. Strehlau Germany 14 104 0.4× 17 0.1× 171 1.6× 295 2.9× 120 1.2× 28 565

Countries citing papers authored by Douglas Charney

Since Specialization
Citations

This map shows the geographic impact of Douglas Charney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Charney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Charney more than expected).

Fields of papers citing papers by Douglas Charney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Charney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Charney. The network helps show where Douglas Charney may publish in the future.

Co-authorship network of co-authors of Douglas Charney

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Charney. A scholar is included among the top collaborators of Douglas Charney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Charney. Douglas Charney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Peyser, Alexandra, Rachel Frank, Suzanne Vento, et al.. (2009). Diagnostic yield of renal biopsies: a retrospective single center review. BMC Nephrology. 10(1). 11–11. 19 indexed citations
2.
Peyser, Alexandra, Rachel Frank, Suzanne Vento, et al.. (2009). IgA Nephropathy: A Twenty Year Retrospective Single Center Experience. SHILAP Revista de lepidopterología. 3. 19–22.
3.
Gholam, Pierre M., Louis Flancbaum, Jason T. Machan, Douglas Charney, & Donald P. Kotler. (2007). Nonalcoholic Fatty Liver Disease in Severely Obese Subjects. The American Journal of Gastroenterology. 102(2). 399–408. 229 indexed citations
4.
Leibman, A. Jill, et al.. (2006). Mucocelelike Lesions of the Breast: Mammographic Findings with Pathologic Correlation. American Journal of Roentgenology. 186(5). 1356–1360. 22 indexed citations
5.
Charney, Douglas, et al.. (2005). A male nephrotic patient with rapid decline of renal function. Nephrology Dialysis Transplantation. 20(6). 1263–1266. 1 indexed citations
6.
Lu, Shengli, et al.. (2005). Pathologic Quiz Case: A 52-Year-Old Woman With a Uterine Mass. Archives of Pathology & Laboratory Medicine. 129(3). e77–e78. 11 indexed citations
7.
Cheema, Sanjay, et al.. (2004). IgA-dominant glomerulonephritis associated with hepatitis A. Clinical Nephrology. 62(8). 138–143. 14 indexed citations
8.
Charney, Douglas & Walter G. Wasser. (2003). A 36-year-old man with a monoclonal gammopathy and nephrotic syndrome. American Journal of Kidney Diseases. 42(5). 1097–1101. 3 indexed citations
9.
Ahsan, Nasimul, et al.. (2002). Polyomavirus Allograft Nephropathy: Parenchymal and Extraparenchymal Manifestations. 5. S98–S103. 1 indexed citations
10.
Kraus, Edward S., et al.. (2001). EFFECT OF Bw4 AND Bw6 EPITOPE MISMATCHES ON ANTIBODY PRODUCTION, ACUTE AND CHRONIC REJECTION, AND GRAFT SURVIVAL IN RENAL ALLOGRAFTS. Transplantation. 72(3). 433–437. 5 indexed citations
11.
Messias, Nidia, Joseph A. Eustace, Andrea A. Zachary, et al.. (2001). COHORT STUDY OF THE PROGNOSTIC SIGNIFICANCE OF ACUTE TRANSPLANT GLOMERULITIS IN ACUTELY REJECTING RENAL ALLOGRAFTS1. Transplantation. 72(4). 655–660. 29 indexed citations
12.
Frank, Douglas K., et al.. (2001). Plasma cell variant of castleman's disease occuring concurrently with Hodgkin's disease in the neck. Head & Neck. 23(2). 166–169. 11 indexed citations
13.
Ripple, Mary, Douglas Charney, & Tibor Nádasdy. (2000). CHOLESTEROL EMBOLIZATION IN RENAL ALLOGRAFTS. Transplantation. 69(10). 2221–2225. 13 indexed citations
14.
Volmar, Keith E., et al.. (2000). Rapidly progressive renal failure with nephrotic syndrome in a patient with type 2 diabetes mellitus: The differential of fibrillary deposits. American Journal of Kidney Diseases. 35(1). 173–177. 7 indexed citations
15.
Charney, Douglas, George M. Nassar, Luan D. Truong, & Tibor Nádasdy. (2000). “pauci-immune” proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome. American Journal of Kidney Diseases. 35(6). 1193–1206. 26 indexed citations
16.
Charney, Douglas, et al.. (1999). PLASMA CELL-RICH ACUTE RENAL ALLOGRAFT REJECTION1. Transplantation. 68(6). 791–797. 78 indexed citations
17.
Prasad, Manju L., et al.. (1998). Pulmonary Immunocytoma With Massive Crystal Storing Histiocytosis. The American Journal of Surgical Pathology. 22(9). 1148–1153. 38 indexed citations
18.
Charney, Douglas, et al.. (1996). Primitive neuroectodermal tumor of the myocardium: A case report, review of the literature, immunohistochemical, and ultrastructural study. Human Pathology. 27(12). 1365–1369. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026